Pirfenidone and chronic progressive obliterative airway disease.
Dosanjh
A
A
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001989:Bronchiolitis Obliterans / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D018450:Disease Progression; D004359:Drug Therapy, Combination; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D011506:Proteins / Q000032:analysis; D011728:Pyridones / Q000627:therapeutic use*; D051381:Rats
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D011506:Proteins; D011728:Pyridones; D016572:Cyclosporine; C093844:pirfenidone